Barclays Maintains Overweight on Molina Healthcare, Raises Price Target to $400

Barclays analyst Steven Valiquette maintains Molina Healthcare (NYSE:MOH) with a Overweight and raises the price target from $380 to $400.

Barclays analyst Steven Valiquette maintains Molina Healthcare (NYSE:MOH) with a Overweight and raises the price target from $380 to $400.

Total
0
Shares
Related Posts